Allergy Therapeutics PLC | Balance Sheet
Fiscal year is July-June. All values GBP Thousands.
2013
2014
2015
2016
2017
2018
Cash & Short Term Investments
1,259.00
2,374.00
21,982.00
23,406.00
22,122.00
15,533
Total Accounts Receivable
5,421.00
4,387.00
4,230.00
5,517.00
6,271.00
6,587
Inventories
6,014.00
6,469.00
6,747.00
7,692.00
7,484.00
8,808
Other Current Assets
1,764.00
981.00
830.00
997.00
1,582.00
-
Total Current Assets
14,458.00
14,211.00
33,789.00
37,612.00
37,459.00
30,928
Net Property, Plant & Equipment
7,337.00
7,030.00
8,750.00
9,667.00
9,673.00
10,096
Intangible Assets
3,910.00
3,771.00
5,000.00
5,355.00
5,459.00
4,949
Other Assets
3,059.00
3,212.00
3,160.00
4,045.00
4,592.00
5,043
Total Assets
28,964.00
28,398.00
51,361.00
57,325.00
57,741.00
51,016
ST Debt & Current Portion LT Debt
288.00
49.00
251.00
295.00
391.00
Accounts Payable
3,050.00
2,464.00
2,819.00
3,110.00
2,881.00
Other Current Liabilities
4,282.00
3,961.00
4,350.00
9,115.00
10,748.00
Total Current Liabilities
7,620.00
6,474.00
7,420.00
12,520.00
14,020.00
Long-Term Debt
3,652.00
3,652.00
1,433.00
3,070.00
2,936.00
Provision for Risks & Charges
6,514.00
6,640.00
6,966.00
10,431.00
9,910.00
Deferred Taxes
41.00
38.00
298.00
334.00
352.00
Other Liabilities
-
73.00
113.00
-
-
Total Liabilities
17,945.00
16,975.00
16,892.00
27,001.00
27,776.00
Common Equity (Total)
11,019.00
11,423.00
34,469.00
30,324.00
29,965.00
Total Shareholders' Equity
11,019.00
11,423.00
34,469.00
30,324.00
29,965.00
Total Equity
11,019.00
11,423.00
34,469.00
30,324.00
29,965.00
Liabilities & Shareholders' Equity
28,964.00
28,398.00
51,361.00
57,325.00
57,741.00
About Allergy Therapeutics
View Profile